Annual Total Assets
$666.37 M
+$260.53 M+64.19%
31 March 2024
Summary:
Immunovant annual total assets is currently $666.37 million, with the most recent change of +$260.53 million (+64.19%) on 31 March 2024. During the last 3 years, it has risen by +$253.88 million (+61.55%). IMVT annual total assets is now at all-time high.IMVT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$515.71 M
-$73.97 M-12.54%
30 September 2024
Summary:
Immunovant quarterly total assets is currently $515.71 million, with the most recent change of -$73.97 million (-12.54%) on 30 September 2024. Over the past year, it has increased by +$223.64 million (+76.57%). IMVT quarterly total assets is now -27.51% below its all-time high of $711.45 million, reached on 31 December 2023.IMVT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.2% | +76.6% |
| 3 y3 years | +61.5% | -9.0% |
| 5 y5 years | +10000.0% | +337.8% |
IMVT Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.2% | -27.5% | +76.6% |
| 5 y | 5 years | at high | >+9999.0% | -27.5% | +371.4% |
| alltime | all time | at high | >+9999.0% | -27.5% | >+9999.0% |
Immunovant Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $515.71 M(-12.5%) |
| June 2024 | - | $589.68 M(-11.5%) |
| Mar 2024 | $666.37 M(+64.2%) | $666.37 M(-6.3%) |
| Dec 2023 | - | $711.45 M(+143.6%) |
| Sept 2023 | - | $292.07 M(-16.8%) |
| June 2023 | - | $351.22 M(-13.5%) |
| Mar 2023 | $405.84 M(-21.3%) | $405.84 M(-11.0%) |
| Dec 2022 | - | $456.24 M(+6.6%) |
| Sept 2022 | - | $428.15 M(-6.7%) |
| June 2022 | - | $458.66 M(-11.0%) |
| Mar 2022 | $515.56 M | $515.56 M(-5.1%) |
| Dec 2021 | - | $543.18 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $566.73 M(+46.1%) |
| June 2021 | - | $388.03 M(-5.9%) |
| Mar 2021 | $412.49 M(+277.1%) | $412.49 M(-4.7%) |
| Dec 2020 | - | $433.03 M(-4.6%) |
| Sept 2020 | - | $453.89 M(+56.4%) |
| June 2020 | - | $290.29 M(+165.4%) |
| Mar 2020 | $109.39 M(>+9900.0%) | $109.39 M(-13.6%) |
| Dec 2019 | - | $126.62 M(+7.5%) |
| Sept 2019 | - | $117.79 M(+0.3%) |
| June 2019 | - | $117.42 M(>+9900.0%) |
| Mar 2019 | - | $324.60 K |
| Dec 2018 | $405.00 K | - |
FAQ
- What is Immunovant annual total assets?
- What is the all time high annual total assets for Immunovant?
- What is Immunovant annual total assets year-on-year change?
- What is Immunovant quarterly total assets?
- What is the all time high quarterly total assets for Immunovant?
- What is Immunovant quarterly total assets year-on-year change?
What is Immunovant annual total assets?
The current annual total assets of IMVT is $666.37 M
What is the all time high annual total assets for Immunovant?
Immunovant all-time high annual total assets is $666.37 M
What is Immunovant annual total assets year-on-year change?
Over the past year, IMVT annual total assets has changed by +$260.53 M (+64.19%)
What is Immunovant quarterly total assets?
The current quarterly total assets of IMVT is $515.71 M
What is the all time high quarterly total assets for Immunovant?
Immunovant all-time high quarterly total assets is $711.45 M
What is Immunovant quarterly total assets year-on-year change?
Over the past year, IMVT quarterly total assets has changed by +$223.64 M (+76.57%)